• The document is an intimation of an Analysts/Investors Presentation on the Financial Results for the first quarter ended June 30, 2026 (Q1 FY27), filed pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015.
  • The enclosed presentation provides a comprehensive overview of the company's Q1 FY27 financial performance, business segments, growth strategy, R&D capabilities, and management team.
  • The presentation includes detailed financial highlights: Q1 FY27 Revenue from Operations was ₹2,931mn, EBITDA was ₹981mn (33% margin), and PAT was ₹783mn (27% margin). This represents a 25% QoQ revenue increase but a 17% YoY decrease.
  • Key business updates include: good traction in Pharma Intermediates & API; R&D center at Hyderabad facilities on track for operationalization by September 2026; Vizag project activities commenced with technical consultants onboard and Consent to Establish approval received; successful fund raising of ₹8,000mn via QIB issue; and receipt of a Silver Medal from EcoVadis for sustainability practices.
  • The presentation also covers the company's product categories (Contrast Media Intermediates, High Intensity Sweeteners, Pharma Intermediates & API), global market positioning, growth drivers, and competitive landscape.
  • Management participants are listed in the presentation, including Executive Chairman Akshay Bansarilal Arora, Managing Director Shiven Akshay Arora, and other key executives.
  • The document includes standard disclaimer language stating that the presentation contains forward-looking statements and that no unpublished price sensitive information (UPSI) is being shared.

Additional Notes Section

  • The document was attached with the Analysts/Investors Presentation deck detailing Q1 FY27 financials and business updates.
  • Financial data was extensively disclosed in the presentation, including quarterly comparisons, segment breakdowns, balance sheet summaries, and shareholder information.
  • The presentation is hosted on the company's investor relations platform and was filed with the stock exchanges.